Ignite Creation Date:
2025-12-24 @ 1:57 PM
Ignite Modification Date:
2026-02-22 @ 3:55 PM
Study NCT ID:
NCT04603495
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2020-10-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-20
First Submit QC Date:
None
Study First Post Date:
2020-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-23
Results First Submit QC Date:
None
Results First Post Date:
2024-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED